Literature DB >> 19246297

[Effects of recombinant human erythropoietin on hypoxia inducible factor-1alpha expression in the retina of rabbits with acute high intraocular pressure].

Jian-ming Wang1, Yan-ping Song, Nai-xue Sun, Na Hui, Shi-ping Zhao, Kai Hu.   

Abstract

OBJECTIVE: To observe the effect of recombinant human erythropoietin (rhEPO) on the expression of hypoxia inducible factor-1alpha (HIF-1alpha) in the retina of rabbits with acute high intraocular pressure and investigate the mechanism of rhEPO in protecting the retina from ischemia-reperfusion injury.
METHODS: Acute high intraocular pressure was induced in the rabbits by perfusion of normal saline into the anterior chamber, and rhEPO was injected subcutaneously. The changes in HIF-1alpha protein expression in the retina was observed by immunohistochemistry on days 1, 3, 7, and 14 after retinal ischemia- reperfusion.
RESULTS: HIF-1alpha expression was not observed in the retina of the normal control rats, but intense HIF-1alpha expression was found in the model group (P<0.01). In rabbits with rhEPO injection and those in the model group, the patterns of HIF-1alpha expression alterations were similar, but the HIF-1alpha-positive cells in the retina were significantly fewer in rhEPO group (P<0.05).
CONCLUSION: rhEPO can down-regulate HIF-1alpha expression in the retina of rabbits with acute high intraocular pressure, which may be one of the mechanisms that rhEPO protects the retina from ischemia-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246297

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  1 in total

1.  Human erythropoietin effect in postoperative visual loss following spine surgery: a case report.

Authors:  Valiollah Hassani; Mohammad Mohsen Homaei; Ali Shahbazi; Mohammad Mahdi Zamani; Saeid Safari; Shermila Nadi; Abolfazl Rahimizadeh; Mohammad Hossein Lashkari; Siamak Alizadeh Zendehrood
Journal:  Anesth Pain Med       Date:  2014-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.